FORM 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 April 18, 2006 Commission File Number 001-14978 SMITH & NEPHEW plc (Registrant's name) 15 Adam Street London, England WC2N 6LA (Address of registrant's principal executive offices) [Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.] Form 20-F X Form 40-F --- --- [Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1).] Yes No X --- --- [Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7).] Yes No X --- --- [Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing information to the Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of 1934.] Yes No X --- --- If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2 (b) : 82- n/a. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Smith & Nephew plc (Registrant) Date: April 18, 2006 By: /s/ Paul Chambers ----------------- Paul Chambers Company Secretary Smith & Nephew Announces Timing Change of First Quarter Results Conference Call 18 April 2006 Smith & Nephew plc, (LSE: SN, NYSE: SNN), the global medical technology business, announces a change in the timing of the first quarter results conference call with financial analysts from 12.30pm BST/7.30am Eastern to 12.00 noon BST/7.00am Eastern on Thursday 27 April 2006. This change is a result of clashes with other industry conference calls taking place on the same day. The release of the announcement of first quarter results will remain at 11.00am BST/ 6.00am Eastern on that day. Enquiries Smith & Nephew UK Julie Allen Tel: +44 (0)20 7401 7646 Investor Relations Co-ordinator Financial Dynamics UK David Yates/Ben Atwell Tel: +44 (0)20 7831 3113 Financial Dynamics US Jonathan Birt Tel: +1 212 850 5634 About us Smith & Nephew is a global medical technology business, specialising in Orthopaedics, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the fastest growing global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The company has over 8,500 employees and operates in 33 countries around the world generating annual sales of $2.6 billion.